Carregant...
Spironolactone in pulmonary arterial hypertension: results of a cross-over study
The renin–angiotensin–aldosterone system is implicated in the pathophysiology of pulmonary arterial hypertension. We undertook this study to determine the effects of spironolactone, a mineralocorticoid receptor blocker, on collagen metabolism in pulmonary arterial hypertension patients. After obtain...
Guardat en:
| Publicat a: | Pulm Circ |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7219009/ https://ncbi.nlm.nih.gov/pubmed/32426108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894019898030 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|